cytarabine has been researched along with Alopecia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (39.29) | 18.7374 |
| 1990's | 13 (46.43) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, X; Huang, ZL; Li, QH; Lin, W; Lu, ZS; Weng, JY; Wu, SJ; Zhong, LY | 1 |
| Aruoma, OI; Fujii, H; Nishioka, H; Sato, E; Sun, B; Wakame, K | 1 |
| Hagiwara, S; Inomata, M; Kitano, S; Koga, H; Moriyama, M; Noguchi, T; Uchida, T; Yoshizumi, F | 1 |
| Forcier, RJ; LeMarbre, PA; Maurer, LH; O'Donnell, JF; Quinn, BM; Stern, R | 1 |
| Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Ciepielewska, D; Kaczmarek-Kanold, M; Kościelniak, E; Ochocka, M; Radwańska, U; Sońta-Jakimczyk, D; Sroczyńska, M | 1 |
| Dhaliwal, HS; Lister, TA; Malpas, JS; Rohatiner, A; Slevin, ML | 1 |
| Hussein, AM | 2 |
| Hussein, AM; Peters, WP; Stuart, A | 1 |
| Benson, W; Danilenko, DM; Pierce, GF; Ring, BD; Starnes, CO; Wiemann, B; Yanagihara, D | 1 |
| Kimura, K; Masaoka, T; Ogawa, M; Yamada, K | 1 |
| Albeck, M; Bruderman, I; Catane, R; Gafter, U; Gal, R; Kalechman, Y; Kaufman, B; Mettinger, KL; Shani, A; Shapira, J; Sredni, B; Tichler, T; Whisnant, JK; Xu, RH | 1 |
| Tada, M; Takahata, K; Tamaki, T; Yazawa, K | 1 |
| Dmoszyńska, A; Kowal, M; Lech-Marańda, E; Robak, T; Wrzesień-Kuś, A | 1 |
| Bedwinek, J; Goldberg, RS; Joss, RA; Krakoff, IH; Yates, JW | 1 |
| Huang, HS; Jimenez, JJ | 1 |
| Huang, HS; Jiménez, JJ; Yunis, AA | 1 |
| Jimenez, JJ; Yunis, AA | 1 |
| Jimenez, JJ; Sawaya, ME; Yunis, AA | 1 |
| Jimenez, JJ; Wong, GH; Yunis, AA | 1 |
| Hussein, AM; Jimenez, JJ; McCall, CA; Yunis, AA | 1 |
| Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M | 1 |
| Fehr, J; Gmür, J; Hofmann, V; Honegger, HP; Morant, R; Sauter, C | 1 |
| Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T | 1 |
| Bertino, JR; DeConti, RC; Farber, LR; Levitt, M; Marsh, JC; Mitchell, MS; Skeel, RT | 1 |
| Bodey, GP; Freireich, EJ; Hart, J; Rodriguez, V | 1 |
| Hurwitz, BS; Walker, MD | 1 |
| Buchanan, JG | 1 |
7 trial(s) available for cytarabine and Alopecia
| Article | Year |
|---|---|
Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Agranulocytosis; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Nausea; Recurrence; Remission Induction; Young Adult | 2009 |
Intensive cytosine arabinoside therapy in small cell carcinoma of the lung.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vincristine; Vomiting | 1984 |
[Early phase II study of Idarubicin combined with cytarabine in acute myelogenous leukemia. Idarubicin Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Female; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged | 1993 |
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Topics: Alopecia; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cytarabine; Cytokines; Dinoprostone; Ethylenes; Female; Humans; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Lung Neoplasms; Macrophages; Male; Rats; Rats, Sprague-Dawley; Sialoglycoproteins | 1996 |
Combination sequential chemotherapy in advanced reticulum cell sarcoma.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Combinations; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nervous System Diseases; Radiography, Thoracic; Remission, Spontaneous; Vincristine | 1972 |
Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
Topics: Acute Disease; Adolescent; Adult; Aged; Alanine Transaminase; Alopecia; Aspartate Aminotransferases; Bone Marrow Diseases; Child; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Cytarabine; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Remission, Spontaneous; Vomiting | 1970 |
BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alopecia; Antineoplastic Agents; Aspartate Aminotransferases; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Bronchogenic; Child; Child, Preschool; Clinical Trials as Topic; Cystitis; Cytarabine; Evaluation Studies as Topic; Female; Glioma; Humans; Leukopenia; Male; Medulloblastoma; Middle Aged; Nitroso Compounds; Nitrosourea Compounds; Thrombocytopenia; Urea | 1970 |
21 other study(ies) available for cytarabine and Alopecia
| Article | Year |
|---|---|
The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.
Topics: Alopecia; Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Body Weight; Cytarabine; Female; Hair Follicle; Male; Mercaptopurine; Methotrexate; Mice; Polysaccharides; Rats; Rats, Sprague-Dawley; Shiitake Mushrooms | 2009 |
The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study.
Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents; Antioxidants; Cytarabine; Hair Follicle; Histidine; Microscopy, Electron, Transmission; Ointments; Rats; Rats, Wistar; Scalp; Thioctic Acid | 2011 |
Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
Topics: Abdominal Neoplasms; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1984 |
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Alopecia; Child; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Middle Aged; Nausea; Neutropenia | 1984 |
Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model.
Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Female; Male; Minoxidil; Rats; Rats, Sprague-Dawley | 1995 |
Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.
Topics: Administration, Cutaneous; Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Cyclophosphamide; Cyclosporine; Cytarabine; Disease Models, Animal; Etoposide; Injections, Intraperitoneal; Rats; Rats, Sprague-Dawley | 1995 |
Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.
Topics: Alopecia; Animals; Animals, Newborn; Cell Differentiation; Cell Division; Cytarabine; Dose-Response Relationship, Drug; Female; Fibroblast Growth Factor 10; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Growth Substances; Hair; In Situ Hybridization; Keratinocytes; Mice; Mice, Nude; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Recombinant Proteins; RNA, Messenger; Sebaceous Glands; Skin | 1995 |
Protection from chemotherapy-induced alopecia by docosahexaenoic acid.
Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Cytarabine; Docosahexaenoic Acids; Etoposide; Female; In Situ Nick-End Labeling; Rats; Rats, Sprague-Dawley | 1999 |
Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia.
Topics: Acute Disease; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Disease-Free Survival; Drug Evaluation; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 2000 |
Combination radiotherapy and chemotherapy for small cell carcinoma of the lung.
Topics: Alopecia; Antineoplastic Agents; Arrhythmias, Cardiac; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Middle Aged; Vomiting | 1979 |
IL-1 synergizes with ARA-C in aborting the development of chloroleukemia while protecting from ARA-C-induced alopecia in the rat model.
Topics: Alopecia; Animals; Cell Differentiation; Cytarabine; Disease Models, Animal; Drug Synergism; In Vitro Techniques; Interleukin-1; Leukemia, Myeloid; Neoplasm Transplantation; Rats | 1992 |
Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia.
Topics: Acetylcysteine; Administration, Topical; Alopecia; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Cyclophosphamide; Cytarabine; Immunologic Factors; Injections, Intraperitoneal; Injections, Subcutaneous; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1992 |
Protection from 1-beta-D-arabinofuranosylcytosine-induced alopecia by epidermal growth factor and fibroblast growth factor in the rat model.
Topics: Alopecia; Animals; Cyclophosphamide; Cytarabine; Epidermal Growth Factor; Fibroblast Growth Factors; Rats; Rats, Inbred Strains; Recombinant Proteins | 1992 |
Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro.
Topics: Alopecia; Animals; Antineoplastic Agents; Biological Products; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Drug Antagonism; Hair; Immunologic Factors; In Vitro Techniques; Interleukin-1; Rats; Rats, Inbred Strains | 1992 |
Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.
Topics: Alopecia; Animals; Animals, Newborn; Cyclophosphamide; Cytarabine; Humans; Interleukin-1; Rats; Rats, Inbred Strains; Recombinant Proteins | 1991 |
Interleukin 1 protects from cytosine arabinoside-induced alopecia in the rat model.
Topics: Alopecia; Animals; Cytarabine; Disease Models, Animal; Interleukin-1; Rats; Rats, Inbred Strains; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Protection from chemotherapy-induced alopecia in a rat model.
Topics: Alopecia; Animals; Biological Products; Cytarabine; Disease Models, Animal; Immunologic Factors; Leukemia, Experimental; Rats; Rats, Inbred F344; Skin | 1990 |
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting | 1986 |
[Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature].
Topics: Adolescent; Adult; Aged; Alopecia; Bone Marrow Diseases; Brain Diseases; Conjunctivitis; Cytarabine; Digestive System Diseases; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1986 |
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine | 1986 |
Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
Topics: Abdomen; Adolescent; Adult; Aged; Alopecia; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cytarabine; Diarrhea; Erythrocytes; Female; Fever; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney Diseases; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ulcer; Vomiting | 1971 |